AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 AC Immune to host symposium ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.

Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potential milestones of up to about $2.1 billion plus royalties on sales upon ...

Geroscience, a new branch of geriatrics and gerontology, postulates that organismal aging and age-associated diseases share the same basic molecular mechanisms. According to this assumption, there is ...

Forty-eight hours after HIFU treatment, all the molecular markers except pTau-181 had risen significantly; however, GFAP rose the most, more than quadrupling on average compared to pre-treatment ...

We've identified the following companies as similar to Port of Tauranga Ltd ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. P-tau 217 had high accuracy in diagnosing Alzheimer ...

This may be due to poor preservation of cellular structures in frozen autopsy brain tissue. SERBP1 and pTau co-staining lacks an age matched non-AD control. Most quantifications of human IHC staining ...

Scientists measured levels of beta-amyloid (Aβ40, Aβ42), pTau-181, NfL, and glial fibrillary acidic protein (GFAP), which are all markers of Alzheimer’s disease. They also assessed the brain ...